Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 47: 2150-2153, 2001;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Opalka, J. R.
Right arrow Articles by Zierz, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Opalka, J. R.
Right arrow Articles by Zierz, S.
Related Collections
Right arrow General Clinical Chemistry
(Clinical Chemistry. 2001;47:2150-2153.)
© 2001 American Association for Clinical Chemistry, Inc.


Articles

Age and Sex Dependency of Carnitine Concentration in Human Serum and Skeletal Muscle

Jens Rüdiger Opalkaa, Frank-Norbert Gellerich and Stephan Zierz

Muskellabor, Universitätsklinik und Poliklinik für Neurologie, Martin-Luther-Universität Halle-Wittenberg, Ernst-Grube-Strasse 40, D-06097 Halle (Saale), Germany

aauthor for correspondence: fax 49-345-557-3505,


   Introduction
 
Carnitine plays an essential role in fatty acid metabolism. It can be synthesized in the liver, but additional intestinal resorption is necessary (1). Carnitine mediates the transport of activated acyl residues via the carnitine palmityl transferase system into mitochondria for ß-oxidation (2). Whereas primary carnitine deficiency is attributable to mutations in OCTN2 [a carnitine transporter of plasma membranes (3)], several other conditions can cause secondary deficiency (4). The leading symptom of either primary or secondary carnitine deficiency is weakness of skeletal muscles. In addition to these pathologic conditions in some animal models, a physiologic decline of carnitine concentration with aging has been reported (5)(6). In addition to increasing muscular carnitine concentrations (6), oral treatment with L-carnitine or its acetyl ester has also been shown to restore many of physiologic impairments that accompany aging (7)(8)(9)(10). These data indicate the important role of carnitine in the aging process, at least in mice and rats. For human skeletal muscle, confusing results exist with respect to the age dependency of carnitine content: Whereas Costell et al. (5) found a "drastic" age-dependent decrease of carnitine in human skeletal muscle and Gonzalez-Crespo et al. (11) detected reduced free carnitine concentrations in elderly patients undergoing hip surgery, an age-dependent decrease in carnitine concentration could not be confirmed by Starling et al. (12). The answer to the question of whether carnitine in human muscle is also age dependent is hampered by the different populations investigated and the different methods used. No reliable data exist concerning the sex dependency of a possible age-dependent variation.

The present study seeks to clarify whether carnitine concentrations in human skeletal muscle and serum depend . . . [Full Text of this Article]


   Acknowledgments
 

   References
 



The following articles in journals at HighWire Press have cited this article:


Home page
Hum ReprodHome page
S. M. Fenkci, V. Fenkci, O. Oztekin, S. Rota, and N. Karagenc
Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome
Hum. Reprod., July 1, 2008; 23(7): 1602 - 1606.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
E. P. BRASS
Carnitine and Sports Medicine: Use or Abuse?
Ann. N.Y. Acad. Sci., November 1, 2004; 1033(1): 67 - 78.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
C. S. Ho, B. S.S. Cheng, and C. W.K. Lam
Rapid Liquid Chromatography-Electrospray Tandem Mass Spectrometry Method for Serum Free and Total Carnitine
Clin. Chem., July 1, 2003; 49(7): 1189 - 1191.
[Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
E. P. Brass
Pivalate-Generating Prodrugs and Carnitine Homeostasis in Man
Pharmacol. Rev., December 1, 2002; 54(4): 589 - 598.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Association for Clinical Chemistry.